Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-26-297859
Filing Date
2026-07-07
Accepted
2026-07-07 21:26:12
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9175
2 EX-99 ck0000000000-ex99.pdf EX-99 178270
  Complete submission text file 0001193125-26-297859.txt   256747
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Subject) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91963 | Film No.: 261160644
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 650-516-4310
SCLX Stock Acquisition JV LLC (Filed by) CIK: 0001994894 (see all company filings)

EIN.: 933031787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A